Biotech Catches Major Premarket Bid
January 10 2023 - 8:45AM
AllPennyStocks.com
A New Jersey-based biotech company is turning
heads on Tuesday after the company announced the first vitiligo
patient was dosed in a Phase 1a/b clinical trial of VYN201.
To read the full story on AllPennyStocks.com, click
here.
VYNE Therapeutics (NASDAQ:VYNE)
Historical Stock Chart
From Jun 2024 to Jul 2024
VYNE Therapeutics (NASDAQ:VYNE)
Historical Stock Chart
From Jul 2023 to Jul 2024